Ledger.Open graph →
SEC Form D · filed February 20, 2018

Bolt Biotherapeutics, Inc

Offering
$6.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Redwood City, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Edgar G. Engleman · Redwood City, CAExec · DirectorGrant G. Yonehiro · Redwood City, CAExecPeter G. Moldt · Pleasanton, CADirectorMahendra G. Shah · Pleasanton, CADirectorWeaver H. Gaines · Newberry, FLExecMir Joffrey · DALLAS, TXDirectorCharles L. Adelmann, M.D · Bridgeport, CTExec · DirectorDante Andrade · Dallas, TXDirectorKen G. Harrison · Redwood City, CADirectorScott Graves · Los Angeles, CAExec · DirectorBryan H. Anderson · Phoenix, AZExecKirk H. Howell · Phoenix, AZDirectorMaximiliano H. Palacio · Phoenix, AZDirectorKen G. Harrison · Redwood City, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗